lung cancer

September 22, 2016

VUMC’s Lehman lands LUNGevity research support

Jonathan Lehman, M.D., Ph.D., instructor in Medicine in the Division of Hematology/Oncology, has received a Career Development Award from LUNGevity, a nonprofit organization that provides support programs for lung cancer patients and families, public education and funding for innovative scientific research.

By VUMC News and Communications
June 9, 2016

VUMC Lung Cancer Screening Center earns recognition

Vanderbilt University Medical Center has been designated a Lung Cancer Screening Center by the American College of Radiology.

By VUMC News and Communications
February 10, 2016

Overcoming lung cancer drug resistance

Vanderbilt investigators have discovered a way to overcome the resistance of some lung cancers to certain targeted therapies, which could lead to more effective treatments for lung cancer patients.

By Marilyn Holt
January 27, 2016

Study identifies new culprit in lung cancer development

A microRNA — a small piece of RNA involved in regulating gene expression — functions as an oncogene to drive the development of lung cancer, Vanderbilt University investigators have discovered.

By Leigh MacMillan
January 21, 2016

Lovly lands cancer research grant from V Foundation

Christine Lovly, M.D., Ph.D., assistant professor of Medicine and Cancer Biology, has been awarded a V Scholar Grant from the V Foundation for Cancer Research.

By VUMC News and Communications
January 14, 2016

VICC helps expand cancer patient’s treatment options

Edward (Ned) Wikle recently celebrated the Christmas holidays with his wife and three young children, a celebration the Jackson, Mississippi-based endodontist, U.S. Navy veteran and cancer patient wasn’t sure he would have.

By VUMC News and Communications
November 19, 2015

VICC’s Horn lands Team Leadership Award from NCI

Leora Horn, M.D., M.Sc., associate professor of Medicine and clinical director of the Thoracic Oncology Program at Vanderbilt-Ingram Cancer Center (VICC), has received a 2015 Cancer Clinical Investigator Team Leadership Award (CCITLA) from the National Cancer Institute (NCI).
By VUMC News and Communications
October 5, 2015

Potential target for lung cancer therapy

The glutamine transporter protein appears to contribute to the survival of lung cancer cells, suggesting it may be a useful diagnostic biomarker and target for therapies.
By Leigh MacMillan
July 30, 2015

Singer’s selfless gift benefits lung cancer program

In a town full of amazing singers, Nashville songstress Dawn Sears’ voice was something special.
By VUMC News and Communications
June 11, 2015

Lung cancer foundation lauds Massion’s contributions

Pierre Massion, M.D., director of the Thoracic Program and an Ingram Professor of Cancer Research at Vanderbilt-Ingram Cancer Center, has been recognized for his pioneering work in lung cancer by the LUNGevity Foundation.
By VUMC News and Communications
April 2, 2015

Study explores driver behind lung cancer tumor progression

Vanderbilt-Ingram Cancer Center investigators have identified the mechanisms used by a gene and its binding protein to drive tumor growth in several forms of cancer, including non-small cell lung cancer.
By VUMC News and Communications
November 20, 2014

Tindle to direct Tobacco Research and Treatment

November is well-known as Lung Cancer Awareness Month. It is also the month that highlights awareness of less publicized forms of cancer including pancreatic cancer and stomach cancer.
By VUMC News and Communications
September 24, 2014

Study finds accuracy of lung cancer imaging varies by region

A new analysis of published studies found that FDG-PET technology is less accurate in diagnosing lung cancer versus benign disease in regions where infections like histoplasmosis or tuberculosis are common.
By VUMC News and Communications
1 … 3 4 5 6 7 8